Novo Nordisk Raises Full-Year Guidance After Strong Wegovy Pill Launch

Novo Nordisk beat expectations as its new weight-loss pill sold fast, boosting sales, prescriptions, and improving its 2026 outlook.

Novo Nordisk Raises Full-Year Guidance After Strong Wegovy Pill Launch
Credit: Bloomberg
Already have an account? Sign in.